TELMISARTAN (Solco Healthcare US, LLC)
Welcome to the PulseAid listing for the TELMISARTAN drug offered from Solco Healthcare US, LLC. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Solco Healthcare US, LLC |
NON-PROPRIETARY NAME: | TELMISARTAN |
SUBSTANCE NAME: | TELMISARTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-08-20 |
END MARKETING DATE: | 0000-00-00 |
TELMISARTAN HUMAN PRESCRIPTION DRUG Details:
Item Description | TELMISARTAN from Solco Healthcare US, LLC |
LABELER NAME: | Solco Healthcare US, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2017-08-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43547-283_7804e132-fde4-4582-bb45-0a06eb13d1c2 |
PRODUCT NDC: | 43547-283 |
APPLICATION NUMBER: | ANDA207882 |
Other TELMISARTAN Pharmaceutical Manufacturers / Labelers: